References: Shingles (herpes zoster)

  • Australian Society for Infectious Diseases (ASID), editor. Management of Perinatal Infections. 3rd ed. 2022. https://asid.net.au/publications
  • McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther 2012;17(2):255-64. https://pubmed.ncbi.nlm.nih.gov/22300753/
  • Meyer JJ, Liu K, Danesh-Meyer HV, Niederer RL. Prompt Antiviral Therapy Is Associated With Lower Risk of Cerebrovascular Accident Following Herpes Zoster Ophthalmicus. Am J Ophthalmol 2022;242:215-20. https://www.ncbi.nlm.nih.gov/pubmed/35809660
  • National Centre for Immunisation Research and Surveillance (NCIRS). Zoster vaccines: Frequently asked questions. Fact Sheet. National Centre for Immunisation Rsearch and Surveillance (NCIRS). 2022; Updated September 2024. Accessed 16/09/24. https://ncirs.org.au/zoster-shingles/zoster-shingles-vaccines-shingrixr-rzv-and-zostavaxr-zvl-frequently-asked-questions
  • Schmader K. Herpes Zoster. Ann Intern Med 2018;169(12):897. https://www.ncbi.nlm.nih.gov/pubmed/30557431
  • Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol 2017;31(1):9-19. https://www.ncbi.nlm.nih.gov/pubmed/27804172
  • Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (S2k) Guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol 2017;31(1):20-9. https://pubmed.ncbi.nlm.nih.gov/27579792/